Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
lomustine (1 trial)
temozolomide (temodar) (1 trial)
dianhydrogalactitol (5 trials)
rem-001 (1 trial)
Brain Neoplasms (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Ovarian Neoplasms (Phase 2)
Trials (7 total)
Trial APIs (5 total)